EUVIMEDEUVIMED entdecken
Crossref

Ozonoterapia en el Síndrome del Túnel Carpiano inducido por Inhibidores de la Aromatasa en pacientes con cáncer de mama. Revisión narrativa con actualización bibliográfica

Mª José Barrera López

Ozone Therapy Global Journal · 22.06.2026 · 15 (1) · 155-181

DOI: 10.67442/xrpwpe61 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ozone Therapy Global Journal, online erschienen am 22.06.2026. Verfasst von Mª José Barrera López.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Breast cancer patients receiving aromatase inhibitors as adjuvant therapy may develop aromatase inhibitor–associated musculoskeletal syndrome in approximately 5–20% of cases, whose most frequent clinical manifestation is carpal tunnel syndrome. Beyond the severity of symptoms experienced by each patient, there is major concern about poor adherence and premature discontinuation of endocrine therapy in up to 20–30% of cases, with consequent negative impact on disease outcomes. Conventional treatments for carpal tunnel syndrome have important limitations: local corticosteroid injections may lead to metabolic disturbances in susceptible patients, are associated with a substantial rate of symptom recurrence, and do not act on the underlying cause, namely sub synovial fibrosis. Surgery is another therapeutic option but likewise does not modify the underlying pathophysiology. These limitations justify the search for complementary and alternative therapeutic approaches.

Objectives

To describe the relationship between the incidence and prevalence of hormone‑dependent breast cancer and the routine use of aromatase inhibitors in clinical practice, and the consequent development of Aromatase Inhibitor-Associated Musculoskeletal Syndrome and carpal tunnel syndrome. To explore the pathophysiology of carpal tunnel syndrome and its diagnostic criteria. To explain the mechanisms of action of ozone therapy in this clinical context. To analyze the scientific evidence on the use of ozone in carpal tunnel syndrome in breast cancer patients and to assess the plausibility and safety profile of ozone as a therapeutic strategy in this population.

Zitieren

APA

López, M. J. B. (2026). Ozonoterapia en el Síndrome del Túnel Carpiano inducido por Inhibidores de la Aromatasa en pacientes con cáncer de mama. Revisión narrativa con actualización bibliográfica. Ozone Therapy Global Journal, 15(1), 155-181. https://doi.org/10.67442/xrpwpe61

Vancouver

López MJB. Ozonoterapia en el Síndrome del Túnel Carpiano inducido por Inhibidores de la Aromatasa en pacientes con cáncer de mama. Revisión narrativa con actualización bibliográfica. Ozone Therapy Global Journal. 2026;15(1):155-181. doi:10.67442/xrpwpe61

BibTeX
@article{Lpez2026,
  author = {López, Mª José Barrera},
  title = {Ozonoterapia en el Síndrome del Túnel Carpiano inducido por Inhibidores de la Aromatasa en pacientes con cáncer de mama. Revisión narrativa con actualización bibliográfica},
  journal = {Ozone Therapy Global Journal},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {155--181},
  doi = {10.67442/xrpwpe61}
}
Kostenlos starten →